Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Xie, Yongling ^a   Wang, Yiyi ^a,b   Zhang, Tao ^a   Ren, Guogang ^c   Yang, Zhuo ^a  

^a NANKAI UNIVERSITY   (China)

^b Tianjin Xiqing Hospital   (China)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

depression; hippocampus; long term potentiation; Morris water maze; nanoparticles zinc oxide (nanoZnO)

Indexed keywords

LIPOPOLYSACCHARIDE; NANOPARTICLE; NEUROTRANSMITTER; ZINC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DENTATE GYRUS; DEPRESSION; ELECTROPHYSIOLOGY; FORCED SWIMMING TEST; LONG TERM POTENTIATION; MALE; MAZE TEST; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NONHUMAN; OPEN FIELD TEST; PERFORANT NERVE TRACT; PRIORITY JOURNAL; SPATIAL MEMORY; ANIMAL; BEHAVIOR; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COGNITION; DISEASE MODEL; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZATION; SHORT TERM MEMORY; SYNAPTIC TRANSMISSION;

ANIMALIA; MUS;

ANIMALS; COGNITION; DENTATE GYRUS; DEPRESSION; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; NANOPARTICLES; PERFORANT PATHWAY; RANDOM ALLOCATION; SPATIAL BEHAVIOR; SYNAPTIC TRANSMISSION; ZINC OXIDE;

EID: 84856474977     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-14     Document Type: Article

References (69)

1. Neuroscience nanotechnology: progress, opportunities and challenges. Silva GA, Nat Rev Neurosci 2006 7 1 65 74 (Pubitemid 41828932)
2. Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. Silva GA, BMC Neurosci 2008 9 Suppl 3 4
3. Toxic potential of materials at the nanolevel. Nel A, Xia T, Mädler L, Li N, Science 2006 311 5761 622 7 (Pubitemid 43191298)
4. Influences of nanoparticle zinc oxide on acutely isolated rat hippocampal CA3 pyramidal neurons. Zhao J, Xu L, Zhang T, Ren G, Yang Z, Neurotoxicology 2009 30 2 220 30
5. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Ellis-Behnke RG, Liang YX, You SW, Tay DK, Zhang S, So KF, Schneider GE, Proc Natl Acad Sci USA 2006 103 13 5054 9
6. Transport of nanoparticles across the rat nasal mucosa. Brooking J, Davis SS, Illum L, J Drug Target 2001 9 4 267 79 (Pubitemid 32776362)
7. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. Lockman PR, Koziara JM, Mumper RJ, Allen DD, J Drug Target 2004 12 9-10 635 41 (Pubitemid 40100711)
8. Nano-interventions for neurodegenerative disorders. Fernandes C, Soni U, Patravale V, Pharmacol Res 2010 62 2 166 78
9. A review of nanoparticle functionality and toxicity on the central nervous system. Yang Z, Liu ZW, Allaker RP, Reip P, Oxford J, Ahmad Z, Ren G, J R Soc Interface 2010 7 Suppl 4 411 22
10. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Lanone S, Boczkowski J, Curr Mol Med 2006 6 6 651 63 (Pubitemid 44377764)
11. Nanoparticle-based diagnosis and therapy. Groneberg DA, Giersig M, Welte T, Pison U, Curr Drug Targets 2006 7 6 643 8 (Pubitemid 43827259)
12. Splendid one-dimensional nanostructures of zinc oxide: a new nanomaterial family for nanotechnology. Wang ZL, ACS Nano 2008 2 10 1987 92
13. The potential environmental impact of engineered nanomaterials. Colvin VL, Nat Biotechnol 2003 21 10 1166 70 (Pubitemid 37203347)
14. Preparation of PbS Nanoparticles by Phase-Transfer Method and Application to Pb-Selective Electrode Based on PVC Membrane. Song W, Wu C, Yin H, Liu X, Sa P, Hu J, Anal Lett 2008 41 15 2844 2859
15. Zinc oxide nanoparticles in modern sunscreens: an analysis of potential exposure and hazard. Osmond MJ, McCall MJ, Nanotoxicology 2010 4 1 15 41
16. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Rasmussen JW, Martinez E, Louka P, Wingett DG, Expert Opin Drug Deliv 2010 7 9 1063 77
17. Nano-zinc oxide damages spatial cognition capability via over-enhanced long term potentiation in hippocampus of Wistar rats. Han D, Tian Y, Zhang T, Ren G, Yang Z, International Journal of Nanomedicine 2011 6 1453 61
18. DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Sharma V, Shukla RK, Saxena N, Parmar D, Das M, Dhawan A, Toxicol Lett 2009 185 3 211 8
19. Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. Hanley C, Layne J, Punnoose A, Reddy KM, Coombs I, Coombs A, Feris K, Wingett D, Nanotechnology 2008 19 29 295103
20. Neurabin in the anterior cingulate cortex regulates anxiety-like behavior in adult mice. Kim SS, Wang H, Li XY, Chen T, Mercaldo V, Descalzi G, Wu LJ, Zhuo M, Mol Brain 2011 4 6
21. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. O'Connor JC, Lawson MA, André C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R, Mol Psychiatry 2009 14 5 511 22
22. Depression as a psychophysical illness phenomenon. Battegay R, Praxis (Bern 1994) 1998 87 8 263 70
23. Reactive nitroxidative species and nociceptive processing: determining the roles for nitric oxide, superoxide, and peroxynitrite in pain. Little JW, Doyle T, Salvemini D, Amino Acids 2010 42 1 75 94
24. Behavioral despair during a water maze learning task in mice. Doe N, Takahashi T, Kiriyama M, Exp Anim 2010 59 2 191 7
25. Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study. Sousa F, Mandal S, Garrovo C, Astolfo A, Bonifacio A, Latawiec D, Menk RH, Arfelli F, Huewel S, Legname G, Galla HJ, Krol S, Nanoscale 2010 2 12 2826 34
26. Morphological and histochemical changes occurring in the brain of rats fed large doses of zinc oxide. Kozik MB, Maziarz L, Godlewski A, Folia Histochem Cytochem (Krakow) 1980 18 3 201 6 (Pubitemid 11172167)
27. Toxicity of zinc oxide (ZnO) nanoparticles on human bronchial epithelial cells (BEAS-2B) is accentuated by oxidative stress. Heng BC, Zhao X, Xiong S, Ng KW, Boey FY, Loo JS, Food Chem Toxicol 2010 48 6 1762 6
28. Effects of surface chemistry on cytotoxicity, genotoxicity, and the generation of reactive oxygen species induced by ZnO nanoparticles. Yin H, Casey PS, McCall MJ, Fenech M, Langmuir 2010 26 19 15399 408
29. Animal models of depression: utility for transgenic research. Porsolt RD, Rev Neurosci 2000 11 1 53 8 (Pubitemid 30006576)
30. The tail suspension test: a new method for screening antidepressants in mice. Steru L, Chermat R, Thierry B, Simon P, Psychopharmacology (Berl) 1985 85 3 367 70 (Pubitemid 15123115)
31. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Dunn AJ, Swiergie AHl, Pharmacol Biochem Behav 2005 81 3 688 93 (Pubitemid 40966817)
32. Intra- and interstrain differences in models of "behavioral despair". Bai F, Li X, Clay M, Lindstrom T, Skolnick P, Pharmacol Biochem Behav 2001 70 2-3 187 92 (Pubitemid 33049928)
33. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Bhaskar S, Tian F, Stoeger T, Kreyling W, de la Fuente JM, Grazú V, Borm P, Estrada G, Ntziachristos V, Razansky D, Part Fibre Toxicol 2010 7 3
34. Brain drug delivery technologies: novel approaches for transporting therapeutics. Temsamani J, Scherrmann JM, Rees AR, Kaczorek M, Pharm Sci Technolo Today 2000 3 5 155 162 (Pubitemid 30261518)
35. Advances in the treatment of neurodegenerative disorders employing nanotechnology. Modi G, Pillay V, Choonara YE, Ann N Y Acad Sci 2010 1184 154 72
36. Mesoporous nitrogen-doped TiO2 for the photocatalytic destruction of the cyanobacterial toxin microcystin-LR under visible light irradiation. Choi H, Antoniou MG, Pelaez M, De la Cruz AA, Shoemaker JA, Dionysiou DD, Environ Sci Technol 2007 41 21 7530 5 (Pubitemid 350071670)
37. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Reddy KM, Feris K, Bell J, Wingett DG, Hanley C, Punnoose A, Appl Phys Lett 2007 90 213902 2139021 2139023
38. Toxicity of nanosized and bulk ZnO, CuO and TiO2 to bacteria Vibrio fischeri and crustaceans Daphnia magna and Thamnocephalus platyurus. Heinlaan M, Ivask A, Blinova I, Dubourguier HC, Kahru A, Chemosphere 2008 71 7 1308 16
39. 3 D characterization of gold nanoparticles supported on heavy metal oxide catalysts by HAADF-STEM electron tomography. Gonzalez JC, Hernández JC, Lápez-Haro M, del Río E, Delgado JJ, Hungría AB, Trasobares S, Bernal S, Midgley PA, Calvino JJ, Angew Chem Int Ed Engl 2009 48 29 5313 5
40. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Brayner R, Ferrari-Iliou R, Brivois N, Djediat S, Benedetti MF, Fiévet F, Nano Lett 2006 6 4 866 70
41. Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors: relationship to c-Fos expression in serotonergic and non-serotonergic neurons in the dorsal raphe nucleus. Bouwknecht JA, Spiga F, Staub DR, Hale MW, Shekhar A, Lowry CA, Brain Res Bull 2007 72 1 32 43 (Pubitemid 46227739)
42. Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice. Ibi D, Takuma K, Koike H, Mizoguchi H, Tsuritani K, Kuwahara Y, Kamei H, Nagai T, Yoneda Y, Nabeshima T, Yamada K, J Neurochem 2008 105 3 921 32 (Pubitemid 351562741)
43. The hippocampus and spatial memory: findings with a novel modification of the water maze. Clark RE, Broadbent NJ, Squire LR, J Neurosci 2007 27 25 6647 54 (Pubitemid 46983439)
44. Chronic brain inflammation impairs two forms of long-term potentiation in the rat hippocampal CA1 area. Min SS, Quan HY, Ma J, Han JS, Jeon BH, Seol GH, Neurosci Lett 2009 456 1 20 4
45. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. Sparkman NL, Buchanan JB, Heyen JR, Chen J, Beverly JL, Johnson RW, J Neurosci 2006 26 42 10709 16
46. "Inflammatory" cytokines: neuromodulators in normal brain? Vitkovic L, Bockaert J, Jacque C, J Neurochem 2000 74 2 457 71 (Pubitemid 30053717)
47. Low-frequency stimulation induces a new form of LTP, metabotropic glutamate (mGlu5) receptor- and PKA-dependent, in the CA1 area of the rat hippocampus. Lante F, de Jésus Ferreira MC, Guiramand J, Récasens M, Vignes M, Hippocampus 2006 16 4 345 60 (Pubitemid 43805440)
48. Developmental switch from LTD to LTP in low frequency-induced plasticity. Lante F, Cavalier M, Cohen-Solal C, Guiramand J, Vignes M, Hippocampus 2006 16 11 981 9 (Pubitemid 44857655)
49. Electrical stimulation protocols for hippocampal synaptic plasticity and neuronal hyper-excitability: are they effective or relevant? Albensi BC, Oliver DR, Toupin J, Odero G, Exp Neurol 2007 204 1 1 13 (Pubitemid 46330292)
50. Formation of the nonfunctional and functional pools of granule cells in the dentate gyrus: role of neurogenesis, LTP and LTD. Lisman J, J Physiol 2011 589 8 1905 1909
51. Involvement of hippocampal synaptic plasticity in age-related memory decline. Foster TC, Brain Res Brain Res Rev 1999 30 3 236 49 (Pubitemid 29531486)
52. Plasticity in the human central nervous system. Cooke SF, Bliss TV, Brain 2006 129 Pt 7 1659 73 (Pubitemid 43999401)
53. Age-related neuroinflammatory changes negatively impact on neuronal function. Lynch MA, Front Aging Neurosci 2010 1 6
54. Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptors. Rosi S, Ramirez-Amaya V, Hauss-Wegrzyniak B, Wenk GL, J Neuroinflammation 2004 1 1 12
55. Post weaning social isolation influences spatial cognition, prefrontal cortical synaptic plasticity and hippocampal potassium ion channels in Wistar rats. Quan MN, Tian YT, Xu KH, Zhang T, Yang Z, Neuroscience 2010 169 1 214 22
56. The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Jayatissa MN, Bisgaard CF, West MJ, Wiborg O, Neuropharmacology 2008 54 3 530 41
57. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Choi DW, Trends Neurosci 1988 11 10 465 9
58. Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression. Holm MM, Nieto-Gonzalez JL, Vardya I, Henningsen K, Jayatissa MN, Wiborg O, Jensen K, Hippocampus 2010 21 4 422 33
59. Cytokines as mediators of depression: what can we learn from animal studies? Dunn AJ, Swiergiel AH, de Beaurepaire R, Neurosci Biobehav Rev 2005 29 4-5 891 909 (Pubitemid 40755469)
60. Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review. Hasselbalch BJ, Knorr U, Kessing LV, J Affect Disord 2010 134 1 20 31
61. Reduced immobility in the forced swim test in mice with a targeted deletion of the leukemia inhibitory factor (LIF) gene. Pechnick RN, Chesnokova VM, Kariagina A, Price S, Bresee CJ, Poland RE, Neuropsychopharmacology 2004 29 4 770 6 (Pubitemid 38402484)
62. Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Szewczyk B, Poleszak E, Sowa-Kucma M, Siwek M, Dudek D, Ryszewska-Pokrasniewicz B, Radziwon-Zaleska M, Opoka W, Czekaj J, Pilc A, Nowak G, Pharmacol Rep 2008 60 5 588 9
63. Zinc and fatty acids in depression. Irmisch G, Schlaefke D, Richter J, Neurochem Res 2010 35 9 1376 83
64. Effect of lattice constant of zinc oxide on antibacterial characteristics. Yamamoto O, Komatsu M, Sawai J, Nakagawa ZE, J Mater Sci Mater Med 2004 15 8 847 51 (Pubitemid 39070211)
65. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, Bruinink A, Stark WJ, Environ Sci Technol 2006 40 14 4374 81 (Pubitemid 44092369)
66. Comparative toxicity of nanoparticulate ZnO, bulk ZnO, and ZnCl2 to a freshwater microalga (Pseudokirchneriella subcapitata): the importance of particle solubility. Franklin NM, Rogers NJ, Apte SC, Batley GE, Gadd GE, Casey PS, Environ Sci Technol 2007 41 24 8484 90 (Pubitemid 350276460)
67. Toxicity of metal oxide nanoparticles in mammalian cells. Jeng HA, Swanson J, J Environ Sci Health A Tox Hazard Subst Environ Eng 2006 41 12 2699 711
68. Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts. Lai JC, Lai MB, Jandhyam S, Dukhande VV, Bhushan A, Daniels CK, Leung SW, Int J Nanomedicine 2008 3 4 533 45
69. The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticles. Ng KW, Khoo SP, Heng BC, Setyawati MI, Tan EC, Zhao X, Xiong S, Fang W, Leong DT, Loo JS, Biomaterials 2011 32 32 8218 25